Moderna Stock Book Value Per Share
| M1RN34 Stock | BRL 12.10 0.05 0.41% |
Moderna fundamentals help investors to digest information that contributes to Moderna's financial success or failures. It also enables traders to predict the movement of Moderna Stock. The fundamental analysis module provides a way to measure Moderna's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Moderna stock.
Moderna |
Moderna Company Book Value Per Share Analysis
Moderna's Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
More About Book Value Per Share | All Equity Analysis
Book Value per Share | = | Common EquityAverage Shares |
Current Moderna Book Value Per Share | 4.65 X |
Most of Moderna's fundamental indicators, such as Book Value Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Moderna is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
| Competition |
In accordance with the recently published financial statements, the book value per share of Moderna is about 4.6491 times. This is 373.48% lower than that of the Healthcare sector and 101.87% lower than that of the Biotechnology industry. The book value per share for all Brazil stocks is 99.76% higher than that of the company.
Moderna Book Value Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Moderna's direct or indirect competition against its Book Value Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Moderna could also be used in its relative valuation, which is a method of valuing Moderna by comparing valuation metrics of similar companies.Moderna is rated below average in book value per share category among its peers.
Moderna Fundamentals
| Return On Equity | 0.84 | |||
| Return On Asset | 0.35 | |||
| Profit Margin | 0.55 % | |||
| Operating Margin | 0.62 % | |||
| Current Valuation | 387.59 B | |||
| Shares Outstanding | 7.68 B | |||
| Price To Book | 4.44 X | |||
| Price To Sales | 19.80 X | |||
| Revenue | 18.47 B | |||
| Gross Profit | 13.86 B | |||
| EBITDA | 13.54 B | |||
| Net Income | 12.2 B | |||
| Cash And Equivalents | 7.99 B | |||
| Cash Per Share | 19.80 X | |||
| Total Debt | 599 M | |||
| Debt To Equity | 0.09 % | |||
| Current Ratio | 1.24 X | |||
| Book Value Per Share | 4.65 X | |||
| Cash Flow From Operations | 13.62 B | |||
| Earnings Per Share | 7.47 X | |||
| Number Of Employees | 3.7 K | |||
| Beta | 1.64 | |||
| Market Capitalization | 349.58 B | |||
| Total Asset | 24.67 B | |||
| Net Asset | 24.67 B |
About Moderna Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Moderna's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Moderna using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Moderna based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Moderna Stock
When determining whether Moderna offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Moderna's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Moderna Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Moderna Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Moderna. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Moderna Stock refer to our How to Trade Moderna Stock guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .